Member Info for Benhowell459

No one wants an argument. There needs to be an objective review of SP's performance and of his fellow directors.

Share price fallen from 9p to 0.5p. PH giving us almost zero benefits. Consolidation has proven NOT to be a success and probably quite costly. MHRA is not their fault but the other 3 issues were poorly handled or poor decisions. MEANWHILE, SP has had a large increase in salary. How can he possibly justify rewarding the lack of progress and failure with the above? Answers on a postcard.

Discussions as to whether he stay or goes will never be unanimous. However the issue of his pay rise will surely be a simple and non contentious conclusion for the majority of shareholders who have been keeping track of basic milestones, strategy and performance...

Am I right in thinking the first payment of a milestone will be 'first dosing' in a trial?

So presumably we will not get an RNS saying "Payment received for XYZ" until someone spots a clinical trial between a CHK1 inhibitor and gemcitabine etc...

I am heartened by the inability of a big pharma to hide all information about progress. We have some very eagle eyed spotters on here who know where to look and what to look for. I am grateful for their efforts.

I'm guessing this isn't a rise, just some action with Bed and ISAs? 900k sell covered by 3x300k buys and a few 100ks covered by a 300k.

Always nice to see blue though.

Sounds like our squeaky chair loving BOD would fit right in then, cobalt.

They can't answer any questions competently either!

Apologies HBD - getting mixed up. Been a long day and attributing hard work and effort to completely wrong person. Hopefully we get a sign through trail recruitment soon..

Thanks for the hunt for 737, SOG. (Just realised the plane that went missing was also 737 - we are none the wiser about where our is either!)

Coincidences aside, I agree - it is intriguing why they would want to keep it hidden from view. But they won't be able to hide new CHK1 volunteer recruitment from us. That info has to be published.

My only concern is we now have zero accountability and haven't the foggiest is anyone is pushing things forward. Could a company have taken it on, not to push it forward to prevent competition? Dodgier and more immoral actions have of course been done in the pursuit of profit.

Fingers crossed our partners did some incredibly detailed due diligence and have covered their backs (and ours) in the contract.

I still can't believe that the BoD listened to voices at the AGM, nodded their heads as if they understood the frustration with a falling sp and have done bu**er all about it. Their PR is woeful. They IR hire does what exactly? The email doesn't work. What exactly is Parker paid for if not to calm the ship and provide sound advice? He has done neither, yet seemingly is awarded by a payrise.

Yes, the science is good but if SAR doesn't exist or has no money, it can't take advantage of the Science!

Will one of them grow a pair, hold their hands up and sort this out! It's unacceptable!

As a junior explorer with income I expected a little more progress on the exploration front since the JV announcement in August. The August JV RNS stated:

"Exploration is expected to commence in September 2023, and will comprise both physical activity within the Licence boundaries (including but not limited to mapping, soil geochemistry, geophysics and drilling), and desktop studies, laboratory analysis and interpretation of data and results."

It would appear that based on the latest update all that's happened is they've acquired a database from Anglo. Is that it? Have they done ANY of the physical activity they said they would?

Also, what on earth have they done at Kakuyu? Has literally any exploration work been done in the last 6-9 months?

Judging by posts this morning and recently, the majority have lost faith in Parker's ability to act decisively and competently.

So, how do we go about forcing his hand?

How do we get across shareholder anger on this?

How do we ensure he understands he cannot keep taking his 50k salary whilst providing woeful guidance?

Nothing has happened since the AGM. They have taken nothing on board. We need to act.

(And please don't reply with "trust the science" - it's such a boring shutdown of conversation. There are so many other crucial aspects to a successful junior pharmaceutical company..

I do think it's bizarre that almost every single building material has gone up in price specially since the start of the pandemic and metal is still stuck in the same range as before.

Almost as if inflation doesn't affect metals. Or, god forbid, someone was controlling the market...

I didn't manage to make it to the AGM '23 version. I would like to know why CB's outlandish forward looking statements were not put to him at the last AGM.

I made it to AGM '22 but there was no definitive answer at this point that he was wrong.

He must be held accountable at the upcoming meeting. Why should anyone believe him? He must prove to us a strategy that will convince those who have been burned (IE. With averages 5p upwards).

"we need more detail on the potential of any future investments outside Manica, where and how much - a 2 or 3 year plan effectively - to make a properly informed decision."

Great idea. How do we go about demanding /requesting information on the strategy for the company going for ward. CB can't just sell off our main asset and then tell is he's going hunting! His utter waffle on the roasties podcast doesn't fill anyone with confidence. I want project timelines and STRATEGY before being convinced. I've had enough of his inability to give a straight answer. Surely he should know that selling off Manica would anger the shareholders..

Damon this was 5 years ago. The comparisons to SAR are now redundant as we are way beyond preclinical now. By March we will (hopefully) have confirmed we are safe in humans, a huge step on from testing in Vivo/vitro.

Also I'd like to think that figure of around 150m (US dollars) would be substantially higher.

The deal is there for the taking. We need business savvy and astute leaders to get the deal.

Hence why people constantly parroting the trust the science line doesn't help. Who do they think will negotiate our slice of cake at the end of the day?! The man in the squeaky chair!

I have zero confidence that SP, Tim and John will be able to navigate a licencing scenario bearing in mind their complete and utter incompetence with managing PR (who is getting paid for doing nothing!?) and shareholder engagement. Granted they have had to deal with the sh*tshow that THE UK clinical trial scene is in and made a good decision to evacuate to Oz but apart from that, the jury is well and truly out.

Do I have confidence they will be able to manage a relationship with a large Pharma partner? No

Do I have confidence they will push back hard if the partner doesn't keep to timelines? No

Do I have confidence they will keep us informed? Look at the evidence. The BoD have said they cannot given info for SRA737 so why would they be in a position to update on 1801?

All in all, the mismanagement of the SP (and the finances) has been woeful. I would like them to take any offer over 400m for the stable. I have zero confidence they could manage any better post licence.

Great post Sheep. It's not difficult to understand. This isn't an iron ore or lithium or uranium explorer. There are plenty of those around - if you want to invest in one of those, Google is your friend and pile on in. How hard is it to understand that isn't what this company is about. I love the fact you're active at your age, but no one's impressed with the bragging of billionaires ringing you up - this isn't primary school. Your business is fundamentally different to that of an explorer. Banging on about how Rupert has got it wrong doesn't help, especially when it won't change and isn't definitely wrong! Rant over.

If we could just keep quiet about Eureka, Kalengwa and how this is all deja vu, just until us LTHers have had the chance to get our money back, that would be great. We can pass the CB bashing responsibility and poisoned chalice onto some other (as yet) unknowing souls and swan off to premium bonds or safehaven FTSE trackers where we won't get angry with Roasties and Zach's interviews. Oh who am I kidding - I'd probably pile it all into AFP...

Surely there are only so many trials being initiated on a weekly basis that involve Chk1 inhibitors, especially those in combination with gemcitabine etc. It should be fairly easy to spot a clinical trial that involves the above. They can keep everything quiet but they can't keep the recruitment of volunteers quiet. From there we can possibly find the registering party and work backwards. Fingers crossed a Chk1 inhibitor pops it's head up on one of those websites sooner rather than later...

It's a strange lull in proceedings. The grief analogy is interesting. Most have accepted Colin is full of manure, has fingers in too many pies for someone, shall we say, with less energy than most, and that he doesn't have shareholder interests at heart.

For anyone who disagrees, what material evidence is there that proves otherwise? No interviews, no PR, poorly set out RNSs with little hyperbole/detail and slow updates on profit.

Why would you do any of the above when you have no need to justify your 125k salary for a couple hours of work a week? And again, if anyone wants to tell me he does more than that, show me what he's done.

I've said before and I'll say again - come AGM time, he needs to be moved on. He's too comfortable and has no need to progress the sp when he's raking it in, presiding over a failure of a marketing strategy. There needs to be a joined up, united effort to hold him to account and remove him, if need be.

It's a strange lull in proceedings.

I must add that SOG and Citizen etc have far more knowledge than me on the selectivity issue. I look forward to a more learned contribution but that was what I took from it.